Atlas Trials

Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients

Clinical trial NCT03359850 · COMPLETED

Trial details

NCT number
NCT03359850
Sponsor
Tesaro, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian NeoplasmsNeoplasmsSolid TumorHepatic Impairment
Start date
2018-02-20
Primary completion
2019-09-16
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.